Fluvoxamine
- TRADE NAMES: Apo-Fluvoxamine; Dumirox; Dumyrox; Faverin; Favoxil; Fevarin; Luvox (Solvay); Maveral
- INDICATIONS: Obsessive-compulsive disorder, depression
- CLASS: Antidepressant, CYP1A2 inhibitor, CYP3A4 inhibitor, Selective serotonin reuptake inhibitor (SSRI)
- HALF-LIFE: 15 hours
Alosetron, Alprazolam, Aminophylline, Amphetamines, Anagrelide, Asenapine, Astemizole, Bendamustine, Clobazam, Clopidogrel, Clozapine, Dextroamphetamine, Diethylpropion, Droperidol, Duloxetine, Isocarboxazid, Linezolid, Lumateperone, MAO inhibitors, Mazindol, Methadone, Methamphetamine, Neratinib, Olanzapine, Oxtriphylline, Phendimetrazine, Phenelzine, Phentermine, Phenylpropanolamine, Pirfenidone, Propranolol, Pseudoephedrine, Ramelteon, Rasagiline, Roflumilast, Ropivacaine, Selegiline, Sibutramine, St John's Wort, Sumatriptan, Sympathomimetics, Tacrine, Tasimelteon, Tizanidine, Tramadol, Tranylcypromine, Trazodone, Troleandomycin, Tryptophan, Ubrogepant, Zolmitriptan
PREGNANCY CATEGORY: C
Investigated for treating COVID-19.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
